More than 5 years after the American Society of Clinical Oncology warned of emerging disparities in precision medicine, ...

The American College of Medical Genetics and Genomics (ACMG) has made considerable efforts to establish such guidelines and benchmarks for clinical NGS testing, but it is difficult to compare ...

In a new publication in Nature Materials, an international team of researchers has developed groundbreaking artificial chains ...

Prospective real world data evaluation of clinical outcomes in metastatic hormone sensitive prostate cancer (MHSPC) patients treated as part of triplet therapy with darolutamide: UK multicenter ...

Efficacy and safety of disitamab vedotin combined with toripalimab as neoadjuvant treatment for patients with locally advanced muscle-invasive bladder cancer: A mono-institutional retrospective study.

but current routine assays such as RT-PCR test just one pathogen at a time, or in the case of multiplexed RT-PCR, lack viral sequence information. Next-generation sequencing (NGS) hybrid capture ...

Traditionally, the detection of tumour-derived actionable variants has relied on NGS testing of tissue biopsies, which are invasive, can be difficult to obtain, and may not capture the molecular ...

As Nigeria continues to grapple with a surge in paternity disputes, scientists say Sanger sequencing via Capillary ...

Deepen your understanding of the evolving applications of next-generation sequencing (NGS) in precision oncology research and routine practice. Learn from your peers' experiences. Focus on new ...

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent,” or the “Company”), a technology-based company with a well-established laboratory services business a ...

Discover how automated liquid handling integration is revolutionizing NGS library preparation in genomic workflows.

Different genomic alterations in DNA damage repair (DDR) pathways occur in 20% to 25% of advanced prostate cancer, including homologous recombination repair (HRR) gene alterations. Identifying the ...